摩通表示，科尔特瓦专注于作物化学业务后，有望上涨。该投行将该股从中性上调至超配，目标价为19美元，较上周五收盘价上涨53%。
Corteva is bound to move higher as it focuses more on its crop chemical business, according to JPMorgan. The investment bank upgraded the stock to overweight from neutral. It has a $19 price target on shares, implying 53% upside from Monday's close.
本月早些时候，科尔特瓦将其种子业务分拆为Vylor公司，旨在优先发展农业化学业务。这一举措有助于推动公司股价上涨，摩通表示。
Earlier this month, Corteva spun out its seed business into Vylor, with the aim of prioritizing its agricultural chemical business. It's a move that should lead the firm's shares higher, according to JPMorgan.
周二在给客户的笔记中，杰弗里·泽卡乌斯(Jeffrey Zekauskas)表示：“科尔特瓦是被抛弃的那部分，我们认为它在当前价格下估值。”
"Corteva is the cast off: and we think it is undervalued at the current price," Jeffrey Zekauskas said Tuesday in a note to clients.
他表示，公司的发展方向是从其他行业参与者处获得新的作物化学分子。这些分子通常具有良好的增长前景和高于平均水平的利润率。
"The direction of the company is to in-license new crop chemical molecules from other industry participants. These molecules tend to have good growth profiles and above-average margins."
该分析师还补充称，科尔特瓦可能会解决其中的一些法律责任，包括有关其配方中使用所谓的永久化学品的诉讼。
The analyst added that Corteva is likely to power through some of its legal liabilities, including a lawsuit over its use of so-called forever chemicals in its formulations .
他还指出，农产品市场的一些价格趋势应该支持科尔特瓦股价的增长。
He also noted that several price trends in the agricultural commodities market should support Corteva's share growth.
“过去三年，由于玉米价格从每蒲式耳6美元以下降至约4美元，作物化学行业一直伴随着负面价格趋势，”泽卡乌斯写道。
"The crop chemical industry has been characterized by negative price trends over the past three years as corn prices moved lower from above $6.00/bu to about $4.00/bu," Zekauskas wrote.
“玉米价格现在接近5美元/蒲式耳，为2027年创造了中性至积极定价的机会，这些我们并未纳入我们的模型。”摩通的看好观点与街头共识一致。
"Corn prices are now near $5/bu, creating an opportunity for neutral to positive pricing in 2027, which we have not built into our model." JPMorgan's call falls in line with consensus on the Street.
LSEG数据显示，覆盖科尔特瓦的23位分析师中，有15位对该股持买入或强力买入评级。
Of the 23 analysts covering Corteva, 15 have a buy or strong buy on the stock, LSEG data shows.
过去一个月，科尔特瓦股价下跌6%，部分原因是其分拆和持续的法律问题，但该股仍然今年上涨23%。
Shares of Corteva have fallen 6% over the past month, partially due to its spinout and ongoing legal issues, but the stock is still up 23% year to date.